As cancer care improves, more people are living with survivorship symptoms, such as fatigue and depression. See 3 ways providers can help patients prepare for life after treatment.
Metastatic bone disease patients find hope with orthopaedic surgery options to decrease fracture risk, improve mobility, and manage pain. Alexandra Callan, M.D., discusses treatment advances and paradigm shifts over the last decade.
Robotic-assisted Whipple surgery for pancreatic cancer is one of the most complex GI procedures – and UT Southwestern is a leader in this field, training U.S. and international surgeons. Explore our Simulation Center and how robotic surgery can benefit patients.
UT Southwestern has developed a simple blood test that can predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
A new radiation therapy approach offers curative potential for gynecologic tumors. Learn about adaptive radiation therapy (ART) and two clinical trials at UT Southwestern to help women with cancer.
The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern's Dr. Hans Hammers helps patients explore its benefits and risks.
Daniel Bowers, M.D., Medical Director of the After the Cancer Experience program, discusses the importance of lifelong care for childhood cancer survivors.
PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.
Men with localized, low- and intermediate-risk prostate cancer are seeking TULSA: an outpatient, alternative to surgery or active surveillance: no incisions, surgery, or radiation required. Learn more.
U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. Jonathan Dowell, M.D., discusses what we know about the risks, as well as ongoing research to reveal more answers.
Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.
This study looked at medical records for patients who were cured of liver cancer at 31 North American medical centers. The findings demonstrate that patients who were treated and cured of their hepatitis C had significantly better survival rates than those patients whose hepatitis C was not treated.
